Tonix Pharmaceuticals Q4 EPS $(0.86) Beats $(1.55) Estimate, Sales $3.80M Miss $5.75M Estimate
Tonix Pharmaceuticals Q4 EPS $(0.86) Beats $(1.55) Estimate, Sales $3.80M Miss $5.75M Estimate
Tonix Pharmicals第四季度每股收益美元（0.86美元）超过预期（1.55美元），销售额为380万美元，低于575万美元的预期
Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(1.55) by 44.52 percent. This is a 75.43 percent increase over losses of $(3.50) per share from the same period last year. The company reported quarterly sales of $3.80 million which missed the analyst consensus estimate of $5.75 million by 33.91 percent.
Tonix Pharmicals（纳斯达克股票代码：TNXP）公布的季度亏损为每股0.86美元，比分析师普遍预期的1.55美元（1.55美元）高出44.52％。与去年同期每股亏损3.50美元（3.50）相比，增长了75.43％。该公司公布的季度销售额为380万美元，比分析师普遍预期的575万美元低33.91％。